1. Impact of Nrf2 overexpression on cholangiocarcinoma treatment and clinical prognosis
   Huisong Lee et al, 2023, Korean Journal of Clinical Oncology CrossRef
2. Bypassing Mechanisms of Mitochondria-Mediated Cancer Stem Cells Resistance to Chemo- and Radiotherapy
   Alex Lyakhovich et al, 2016, Oxidative Medicine and Cellular Longevity CrossRef
3. Cellular localization of NRF2 determines the self-renewal and osteogenic differentiation potential of human MSCs via the P53–SIRT1 axis
   D S Yoon et al, 2016, Cell Death & Disease CrossRef
4. The molecular mechanisms of drug resistance of glioblastoma. Part 3. Differentiation and apoptosis of glioblastoma cells
   Alexander N. Chernov et al, 2023, Medical academic journal CrossRef
5. Discovery and Mechanistic Elucidation of a Class of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma
   Anahita Kyani et al, 2018, ChemMedChem CrossRef
6. High-Dose Intravenous Vitamin C Treatment of a Child with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Case Report
   Nina Mikirova et al, 2016, American Journal of Case Reports CrossRef
7. A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis
   Zhifang Hu et al, 2020, Frontiers in Oncology CrossRef
8. The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance
   Lina Alhaddad et al, 2022, International Journal of Molecular Sciences CrossRef
9. Pharmacological intervention in oxidative stress as a therapeutic target in neurological disorders
   Sudhanshu Sharma et al, 2022, Journal of Pharmacy and Pharmacology CrossRef
10. Exploring the Pivotal Neurophysiologic and Therapeutic Potentials of Vitamin C in Glioma
    Seidu A. Richard et al, 2021, Journal of Oncology CrossRef
11. ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies
    Mariagrazia Rinaldi et al, 2016, International Journal of Molecular Sciences CrossRef
12. Borax induces ferroptosis of glioblastoma by targeting HSPA5/NRF2/GPx4/GSH pathways
    Cengiz Tuncer et al, 2024, Journal of Cellular and Molecular Medicine CrossRef
13. Exploring the role of Nrf2 signaling in glioblastoma multiforme
    Wireko Andrew Awuah et al, 2022, Discover Oncology CrossRef
14. Induction of NAD(P)H:Quinone Oxidoreductase 1 (NQO1) by Glycyrrhiza Species Used for Women’s Health: Differential Effects of the Michael Acceptors Isoliquiritigenin and Licochalcone A
    Atieh Hajirahimkhan et al, 2015, Chemical Research in Toxicology CrossRef
15. Role of Interleukin-10 in Acute Brain Injuries
    Joshua M. Garcia et al, 2017, Frontiers in Neurology CrossRef
16. Photodynamic therapy of Glioblastoma cells using doped conjugated polymer nanoparticles: An in vitro comparative study based on redox status
    Matías Daniel Caverzán et al, 2020, Journal of Photochemistry and Photobiology B: Biology CrossRef
17. The molecular mechanisms of drug resistance of glioblastoma: differentiation and apoptosis
    A. N. Chernov et al, 2024, Russian Journal for Personalized Medicine CrossRef
18. Targeting the NF-E2-Related Factor 2 Pathway: a Novel Strategy for Traumatic Brain Injury
    Li Zhang et al, 2018, Molecular Neurobiology CrossRef
19. The Impact of ROS and NGF in the Gliomagenesis and their Emerging Implications in the Glioma Treatment
    Francesca Fanfarillo et al, 2024, CNS & Neurological Disorders - Drug Targets CrossRef
20. Targeting Nrf2-Mediated Oxidative Stress Response Signaling Pathways as New Therapeutic Strategy for Pituitary Adenomas
    Xianquan Zhan et al, 2021, Frontiers in Pharmacology CrossRef
21. Potential targets and treatments affect oxidative stress in gliomas: An overview of molecular mechanisms
    Shiyu Liu et al, 2022, Frontiers in Pharmacology CrossRef